Literature DB >> 16707446

Acid-mediated tumor invasion: a multidisciplinary study.

Robert A Gatenby1, Edward T Gawlinski, Arthur F Gmitro, Brant Kaylor, Robert J Gillies.   

Abstract

The acid-mediated tumor invasion hypothesis proposes altered glucose metabolism and increased glucose uptake, observed in the vast majority of clinical cancers by fluorodeoxyglucose-positron emission tomography, are critical for development of the invasive phenotype. In this model, increased acid production due to altered glucose metabolism serves as a key intermediate by producing H(+) flow along concentration gradients into adjacent normal tissue. This chronic exposure of peritumoral normal tissue to an acidic microenvironment produces toxicity by: (a) normal cell death caused by the collapse of the transmembrane H(+) gradient inducing necrosis or apoptosis and (b) extracellular matrix degradation through the release of cathepsin B and other proteolytic enzymes. Tumor cells evolve resistance to acid-induced toxicity during carcinogenesis, allowing them to survive and proliferate in low pH microenvironments. This permits them to invade the damaged adjacent normal tissue despite the acid gradients. Here, we describe theoretical and empirical evidence for acid-mediated invasion. In silico simulations using mathematical models provide testable predictions concerning the morphology and cellular and extracellular dynamics at the tumor-host interface. In vivo experiments confirm the presence of peritumoral acid gradients as well as cellular toxicity and extracellular matrix degradation in the normal tissue exposed to the acidic microenvironment. The acid-mediated tumor invasion model provides a simple mechanism linking altered glucose metabolism with the ability of tumor cells to form invasive cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707446     DOI: 10.1158/0008-5472.CAN-05-4193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  260 in total

1.  The pH sensitivity of -NH exchange in LnDOTA-tetraamide complexes varies with amide substituent.

Authors:  Ana Christina L Opina; Yunkou Wu; Piyu Zhao; Garry Kiefer; A Dean Sherry
Journal:  Contrast Media Mol Imaging       Date:  2011 Nov-Dec       Impact factor: 3.161

Review 2.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

Review 3.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

4.  Protonation and Trapping of a Small pH-Sensitive Near-Infrared Fluorescent Molecule in the Acidic Tumor Environment Delineate Diverse Tumors in Vivo.

Authors:  Rebecca C Gilson; Rui Tang; Avik Som; Chloe Klajer; Pinaki Sarder; Gail P Sudlow; Walter J Akers; Samuel Achilefu
Journal:  Mol Pharm       Date:  2015-11-04       Impact factor: 4.939

5.  Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Authors:  Mark Robertson-Tessi; Robert J Gillies; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

6.  Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice.

Authors:  Hiroki Wakabayashi; Satoshi Wakisaka; Toru Hiraga; Kenji Hata; Riko Nishimura; Makoto Tominaga; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2017-05-17       Impact factor: 2.626

7.  Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.

Authors:  Liu Qi Chen; Christine M Howison; Justin J Jeffery; Ian F Robey; Phillip H Kuo; Mark D Pagel
Journal:  Magn Reson Med       Date:  2013-11-26       Impact factor: 4.668

8.  Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells.

Authors:  Jing Chen; Xun Hu; Jingjie Cui
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

9.  Computer simulation of glioma growth and morphology.

Authors:  Hermann B Frieboes; John S Lowengrub; S Wise; X Zheng; Paul Macklin; Elaine L Bearer; Vittorio Cristini
Journal:  Neuroimage       Date:  2007-03-23       Impact factor: 6.556

10.  The malignant phenotype of breast cancer cells is reduced by COX-2 silencing.

Authors:  Ioannis Stasinopoulos; Noriko Mori; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.